Sunday, July 5, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
FDA CLEAREDHemolase Fiber (Hemo-R-0.40-2.5/Hemo-R-0.60-2.5/Hemo-R-0.40-1.8/Hemo-R-0.60-1.8) — Micro-Energy Medical Technology Co., Ltd.2 weeks agoFDA CLEAREDLipocosm Harmonic System — Lipocosm, LLC4 weeks agoFDA CLEAREDLED Light Therapy Mask (K9C-TK, K9C-K, K9P-YK, K9P-K, FM-03BK, FM-09K) — Guangdong Newdermo Biotech Co., Ltd.2 weeks agoFDA CLEAREDERBECRYO 2 Cryosurgical Unit and Accessories — Erbe Elektromedizin GmbH4 weeks agoFDA CLEAREDCoolSeal Generator® (CSL-200-90) — Hologic, Inc.3 weeks agoFDA CLEAREDBarbed PDO Suture — Sutura Medical Technology, Inc.3 weeks agoFDA CLEAREDPICOSURE WORKSTATION — Cynosure, LLC3 weeks agoFDA CLEAREDIntense Pulsed Light Therapy Device — Sanhe LEFIS Electronics Co., Ltd.3 weeks agoFDA CLEAREDLED Neck Beauty Mask (ZLD-66A,ZLD-90E,ZLD-130,ZLD-180H) — Shenzhen Kaiyan Medical Equipment Co., Ltd.3 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Devices & Tech

Queen City Dermatology Becomes First Cincinnati Practice to Offer XERF Radiofrequency

Regional adoption of Cynosure's RF platform expands competitive device landscape.

Image: Inside MedSpa

Queen City Dermatology in Cincinnati has become the first practice in the region to introduce XERF radiofrequency skin tightening, reflecting broader market penetration of Cynosure's RF platform outside major coastal markets. Regional adoption signals that practices in secondary markets are increasingly investing in premium RF devices to compete on clinical capability and patient outcomes.

Regional RF adoption accelerates; first-mover advantage in secondary markets drives competitive positioning.

XERF's fractional RF approach targets dermal remodeling for skin laxity, competing directly with established platforms like Morpheus8 and Secret RF. First-mover advantage in regional markets often translates to patient perception of clinical leadership and can justify premium pricing. For practices considering RF investment, regional adoption patterns offer a useful signal: if competitors in your market are deploying XERF or similar platforms, device differentiation becomes harder and volume-based economics become more critical to justify capital expenditure.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo